Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 4 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 4Ovarian Hyperstimulation Syndrome 1Hypertension 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × ganirelix × Clear all
NCT05751252 2025-04-27

SOPKGANI

University Hospital, Lille

Phase EARLY_PHASE1 Completed
20 enrolled

Polycystic Ovary Syndrome

NCT04327934 2024-02-02

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Terminated
28 enrolled 17 charts

Hypertension, Polycystic Ovary Syndrome

NCT00757185 2016-07-04

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Completed
28 enrolled

Polycystic Ovary Syndrome

NCT00417144 2006-12-29

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

Eugonia

Phase 4 Unknown
200 enrolled
Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡